Acetaminophen and NSAID Toxicity

References

Anand BS, Romero JJ, et al. Phospholipid association reduces the gastric mucosal toxicity of aspirin in human subjects. Am J Gastroenterol. 1999 Jul;94(7):1818–22.

Ankeer A. Acetaminophen. In: Ford MD et al, eds. Clinical Toxicology. 1st ed. St. Louis, Mo: W. B. Saunders; 2001:265–73.

Bandarage UK, Janero DR. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs: Novel gastrointestinal-sparing drugs. Mini Rev Med Chem. 2001 May;1(1):57–70.

Bartlett D. Acetaminophen toxicity. J Emerg Nurs. 2004 Jun;30(3):281–3.

Basaga H, Poli G, et al. Free radical scavenging and antioxidative properties of ‘silibin’ complexes on microsomal lipid peroxidation. Cell Biochem Funct. 1997;15(1):27–33.

Becker JC, Domschke W, et al. Current approaches to prevent NSAID-induced gastropathy--COX selectivity and beyond. Br J Clin Pharmacol. 2004 Dec;58(6):587-600.

Beers MM et al, eds. The Merck Manual: The Second Home Edition. Whitehouse Station, NJ: Merck Research Laboratories; 2005.

Brestel E. Allergic conditions. In: McClatchey K, ed. Clinical Laboratory Medicine. Baltimore, Md: Williams & Wilkins; 1994:1643.

Bromer MQ, Black M. Acetaminophen hepatotoxicity. Clin Liver Dis. 2003 May;7(2):351–67.

Davila JC, Lenherr A, et al. Protective effect of flavonoids on drug-induced hepatotoxicity in vitro. Toxicology. 1989;57(3):267–86.

Derby LE, Jick H. Acetaminophen and renal and bladder cancer. Epidemiology. 1996 Jul;7(4):358–62.

Faintuch J, Aguilar PB, et al. Relevance of N-acetylcysteine in clinical practice: Fact, myth or consequence? Nutrition. 1999 Feb;15(2):177–9.

Flora K, Hahn M, et al. Milk thistle (Silybum marianum) for the therapy of liver disease. Am J Gastroenterol. 1998;93(2):139–43.

Ford MD, et al, eds. Clinical Toxicology. 1st ed. St. Louis, Mo: W. B. Saunders; 2001.

Gago-Dominguez M, Yuan JM, et al. Regular use of analgesics is a risk factor for renal cell carcinoma. Br J Cancer. 1999 Oct;81(3):542–8.

Harris Interactive, Inc. Attitudes and Beliefs About the Use of Over-the-Counter Medications: A Dose of Reality. Available at: www.bemedwise.org/survey/final_survey.pdf. Accessed September 19, 2005.

Harris RA, Crabb DW. Metabolic interrelationships. In: Devlin TM, ed. Textbook of Biochemistry with Clinical Correlations. 5th ed. New York: Wiley-Liss; 2002:862–98.

Kaye JA, Myers MW, et al. Acetaminophen and the risk of renal and bladder cancer in the general practice research database. Epidemiology. 2001 Nov;12(6):690–4.

Leyck S, Dereu N, et al. Improvement of the gastric tolerance of non-steroidal anti-inflammatory drugs by polyene-phosphatidylcholine (Phospholipon 100). Eur J Pharmacol. 1985 Oct 29;117(1):35–42.

Marcus R, Coulston AM. Fat soluble vitamins: Vitamins A, K, and E. In: Goodman LS, Gilman A, et al, eds. Pharmacological Basis of Therapeutics. 19th ed. New York: McGraw-Hill; 2001:1773.

Muriel P, Garciapina T, et al. Silymarin protects against paracetamol-induced lipid peroxidation and liver damage. J Appl Toxicol. 1992;12(6):439–42.

O’Malley P. Too much of a good thing: Paracetamol (acetaminophen) toxicity: Update for the clinical nurse specialist. Clin Nurse Spec. 2005 Jan;19(1):18–9.

Oz HS, McClain CJ, et al. Diverse antioxidants protect against acetaminophen hepatotoxicity. J Biochem Mol Toxicol. 2004;18(6):361–8.

Peura DA. Gastrointestinal safety and tolerability of nonselective nonsteroidal anti-inflammatory agents and cyclooxygenase-2-selective inhibitors. Cleve Clin J Med. 2002;69(Suppl 1):SI31–SI39.

Roberts LJ II, Morrow JD. Analgesic-antipyretic and antiinflammatory agents. In: Goodman LS, Gilman A, et al, eds. Pharmacological Basis of Therapeutics. 19th ed. New York: McGraw-Hill; 2001:687.

Schoenfeld P, Kimmey MB, et al. Review article: nonsteroidal anti-inflammatory drug-associated gastrointestinal complications--guidelines for prevention and treatment. Aliment Pharmacol Ther. 1999 Oct;13(10):1273-85.

Sener G, Sehirli AO, et al. Protective effects of melatonin, vitamin E and N-acetylcysteine against acetaminophen toxicity in mice: A comparative study. J Pineal Res. 2003 Aug;35(1):61–8.

Shear NH, Malkiewicz IM, et al. Acetaminophen-induced toxicity to human epidermoid cell line A431 and hepatoblastoma cell line Hep G2, in vitro, is diminished by silymarin. Skin Pharmacol. 1995;8(6):279–91.

Whelton A, Hamilton CW. Nonsteroidal anti-inflammatory drugs: Effects on kidney function. J Clin Pharmacol. 1991 Jul;31(7):588–98.

Wu E. Diagnostic enzymology. In: McClatchey K, ed. Clinical Laboratory Medicine. Baltimore, Md: Williams & Wilkins; 1994:264–65.

These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure or prevent any disease. The information provided on this site is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional or any information contained on or in any product label or packaging. You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. You should consult with a healthcare professional before starting any diet, exercise or supplementation program, before taking any medication, or if you have or suspect you might have a health problem. You should not stop taking any medication without first consulting your physician.